等待开盘 02-04 09:30:00 美东时间
+12.340
+4.33%
今日重点评级关注:HC Wainwright & Co.:维持Praxis Precision Medicine"买入"评级,目标价从340美元升至1245美元;HC Wainwright & Co.:维持Perspective Therapeutics"买入"评级,目标价从10美元升至12美元
02-02 14:15
Celestica (($TSE:CLS)) has held its Q4 earnings call. Read on for the main high...
02-01 08:18
In the preceding three months, 4 analysts have released ratings for Celestica (...
01-31 02:00
Barclays analyst George Wang maintains Celestica (NYSE:CLS) with a Overweight and raises the price target from $359 to $391.
01-30 23:57
BUZZ-U.S. STOCKS ON THE MOVE-Lockheed Martin, ManpowerGroup, Parker-Hannifin Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes slid to over one-week lows on
01-30 02:48
华盛资讯1月29日讯,天弘科技公布2025财年Q4业绩,公司Q4营收36.55亿美元,同比增长43.6%,归母净利润2.68亿美元,同比增长76.3%。
01-29 15:47
Celestica Inc. announced that its 2026 Annual Shareholder Meeting will be held on May 19, 2026, in a hybrid format. The record date for determining eligible shareholders is March 27, 2026. The company will use the notice-and-access method to deliver proxy materials, which will be available on its website and regulatory platforms. Shareholders can access the meeting, submit questions, and vote online. Celestica is a global leader in data center in...
01-29 12:30